Insider: Kumar Neil Chief Executive Officer - BridgeBio Pharma, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 243,581 | 4,438,447 | 4,682,028 |
| Value | $17,817,950.15 | $324,672,398.05 | $342,490,348.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/13/2026 | DDS | 9,759 | Indirect | COM | $69.23 | $675,567.75 | 4,438,447 |
| 03/13/2026 | DDS | 9,690 | Indirect | COM | $68.36 | $662,441.35 | 645,996 |
| 03/13/2026 | DDS | 10,310 | Indirect | COM | $69.20 | $713,448.91 | 635,686 |
| 03/13/2026 | DDS | 10,241 | Indirect | COM | $68.39 | $700,345.12 | 4,448,206 |
| 03/12/2026 | DDS | 14,337 | Indirect | COM | $68.48 | $981,809.23 | 661,349 |
| 03/12/2026 | DDS | 5,363 | Indirect | COM | $69.32 | $371,750.29 | 655,986 |
| 03/12/2026 | DDS | 300 | Indirect | COM | $70.15 | $21,045.00 | 655,686 |
| 03/12/2026 | DDS | 300 | Indirect | COM | $70.15 | $21,045.00 | 4,458,447 |
| 03/12/2026 | DDS | 5,815 | Indirect | COM | $69.29 | $402,928.91 | 4,458,747 |
| 03/12/2026 | DDS | 13,885 | Indirect | COM | $68.47 | $950,686.51 | 4,464,562 |
| 02/19/2026 | DDS | 18,923 | Direct | COM | $71.03 | $1,344,189.63 | 243,581 |
| 02/19/2026 | DDS | 8,528 | Direct | COM | $72.08 | $614,701.65 | 235,053 |
| 02/19/2026 | DDS | 602 | Direct | COM | $72.80 | $43,826.20 | 234,451 |
| 02/11/2026 | DDS | 4,484 | Indirect | COM | $72.64 | $325,695.34 | 679,680 |
| 02/11/2026 | DDS | 7,806 | Indirect | COM | $70.69 | $551,795.99 | 687,880 |
| 02/11/2026 | DDS | 3,994 | Indirect | COM | $73.25 | $292,574.48 | 675,686 |
| 02/11/2026 | DDS | 3,716 | Indirect | COM | $71.44 | $265,476.99 | 684,164 |
| 02/11/2026 | DDS | 7,860 | Indirect | COM | $70.70 | $555,705.93 | 4,490,587 |
| 02/11/2026 | DDS | 3,961 | Indirect | COM | $73.25 | $290,145.23 | 4,478,447 |
| 02/11/2026 | DDS | 4,404 | Indirect | COM | $72.65 | $319,938.27 | 4,482,408 |
| 02/11/2026 | DDS | 3,775 | Indirect | COM | $71.46 | $269,754.33 | 4,486,812 |
| 02/10/2026 | DDS | 14,201 | Indirect | COM | $71.80 | $1,019,657.36 | 701,485 |
| 02/10/2026 | DDS | 5,799 | Indirect | COM | $72.28 | $419,165.06 | 695,686 |
| 02/10/2026 | DDS | 14,040 | Indirect | COM | $71.80 | $1,008,006.01 | 4,504,407 |
| 02/10/2026 | DDS | 5,960 | Indirect | COM | $72.27 | $430,751.25 | 4,498,447 |
| 1 2 3 4 5 6 7 Next Last You are at page 1 of 7 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research